PeptidePedia The community reference

Contributions of BPC_Bramwell

User contributions·17 logged edits·page 1 of 1

Contributions by BPC_Bramwell, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 9,877 edits includes activity predating the current log.

  1. 09:43, 12 Jun 2026 (diff | hist) Retention time 4,104 ±0 convert the method-comparison paragraph to a table
  2. 11:26, 24 May 2026 (diff | hist) Global access disparity 4,391 ±0 add the prior-authorisation criterion as attributed to the payer document
  3. 06:40, 22 Mar 2026 (diff | hist) Trial data comparison 7,303 ±0 add the axis labels to the inline bar figure
  4. 11:09, 5 Feb 2026 (diff | hist) Shanghai Sigma-Audley New Material Technology 15,579 +220 m correct the regional-warehouse list — six sites, not five
  5. 14:59, 7 Jan 2026 (diff | hist) Drug master file 4,325 ±0 add category for drug regulation
  6. 03:03, 7 Jan 2026 (diff | hist) SELECT trial 5,171 ±0 m expand §Design
  7. 19:07, 22 Aug 2025 (diff | hist) Solid-phase peptide synthesis 5,359 ±0 give the closure integrity test by name
  8. 13:48, 31 Jul 2025 (diff | hist) MOTS-c 4,435 ±0 attribute the half-life to the species it was measured in
  9. 14:38, 19 Jun 2025 (diff | hist) Arcuate nucleus 4,363 ±0 add see also to the sister hormone
  10. 14:21, 28 May 2025 (diff | hist) Xi'an Mokemei Biotechnology 5,787 +536 m rm the discount code added by an anonymous editor
  11. 01:03, 17 May 2025 (diff | hist) Subcutaneous injection 4,640 +559 m state the assumption that the whole vial is reconstituted at once
  12. 03:00, 6 May 2025 (diff | hist) Glucagon-like peptide-1 11,229 +977 the numbers in the lead disagreed with the body; body was right
  13. 20:23, 9 Apr 2025 (diff | hist) Glucagon 5,754 ±0 sentence case in headings per PP:MOS
  14. 05:54, 20 Mar 2025 (diff | hist) Subcutaneous injection 4,039 ±0 the vial strength in the example was inconsistent between two paragraphs
  15. 17:29, 18 Jan 2025 (diff | hist) MOTS-c 2,663 +54 m fix a dangling clause
  16. 09:05, 5 Jan 2025 (diff | hist) MOTS-c 2,609 +558 m correct the residue numbering — the source numbers from the mature peptide
  17. 07:10, 22 Jun 2024 (diff | hist) Glucagon-like peptide-1 1,486 ±0 give the magnitude of the incretin effect as a percentage of the insulin response